Literature DB >> 10691596

Venlafaxine-associated hepatitis.

X Cardona, A Avila, P Castellanos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691596     DOI: 10.7326/0003-4819-132-5-200003070-00016

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Hepatotoxic effects with high-dose venlafaxine.

Authors:  Richard C Christensen; Lorrie K Garces
Journal:  Psychiatry (Edgmont)       Date:  2006-07

2.  Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal Dysfunction.

Authors:  Elham Ahmadian; Hossein Babaei; Alireza Mohajjel Nayebi; Aziz Eftekhari; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 3.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

Review 4.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.